Tenaya Therapeutics Inc (TNYA)
4.65
-0.03
(-0.64%)
USD |
NASDAQ |
May 02, 14:18
Tenaya Therapeutics Cash from Financing (Quarterly): 0.371M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.371M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 4.179M |
| March 31, 2023 | -0.501M |
| December 31, 2022 | 77.49M |
| September 30, 2022 | 0.006M |
| June 30, 2022 | 0.26M |
| March 31, 2022 | 0.015M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.021M |
| September 30, 2021 | 190.27M |
| June 30, 2021 | -1.298M |
| March 31, 2021 | 20.02M |
| December 31, 2020 | 85.92M |
| September 30, 2020 | 30.70M |
| June 30, 2020 | -0.021M |
| March 31, 2020 | 30.67M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.298M
Minimum
Jun 2021
190.27M
Maximum
Sep 2021
27.38M
Average
0.3155M
Median
Cash from Financing (Quarterly) Benchmarks
| Adverum Biotechnologies Inc | 0.166M |
| Solid Biosciences Inc | 0.505M |
| Dyne Therapeutics Inc | 0.147M |
| Sana Biotechnology Inc | 1.718M |
| Prime Medicine Inc | 0.194M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -21.92M |
| Cash from Investing (Quarterly) | -14.92M |
| Free Cash Flow | -103.31M |
| Free Cash Flow Per Share (Quarterly) | -0.2999 |
| Free Cash Flow Yield | -30.14% |